FDA Drug Information Updates
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
Also on
Recent episodes
- The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
- The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
- FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
- FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
- FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
- FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
- FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
- FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
- FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk